Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2020 / May / Breakthroughs in Laboratory Medicine
Microbiology & Immunology Technology and innovation Microbiology and Immunology Genetics and epigenetics Neurology Research and Innovations

Breakthroughs in Laboratory Medicine

A snapshot of the latest news in pathology and lab medicine

By Luke Turner 05/20/2020 Quick Read (pre 2022) 1 min read

Share

Age-related ventricular enlargement is linked to a lag in blood drainage from a deep brain region. Left unchecked, ventriculomegaly can lead to issues such as dementia – but the measurement of drainage pathways with diagnostic MRI could provide a new way to predict its onset in aging brains (1).

Graft-versus-host disease (GvHD) is common after allogeneic hematopoietic stem cell transplantation when donor white blood cells attack the recipient’s tissues. New research has found that mutations in mTOR – a gene that regulates cell growth and survival – are common in patients with chronic GvHD, offering a potential target for therapy (2).

White blood cell count, absolute neutrophil count, C-reactive protein (CRP), and procalcitonin are indicators of infection response – but they don’t reliably predict the severity of community-acquired pneumonia in children. Although not associated with the full spectrum of severity, elevated CRP and procalcitonin levels were the findings most closely linked to complicated pneumonia (3).

A new biosensor for diagnosing and monitoring autoimmune disorders can measure the concentration of autoantibodies in blood and quantify their activity. Taking as little as 25 minutes to run, the tool aims to improve existing inconsistencies in the measurement of autoantibody concentration (4).

A team from the University of California, Berkeley has reviewed alternative nucleic acid testing approaches for COVID-19. With an explosion in papers evaluating comparable reagents and potential advances, the researchers hope the review will consolidate and disseminate vital information (5).

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. T Aso et al., Brain, [Epub ahead of print] (2020). PMID: 32372102.
  2. D Kim et al., Nat Comms, 11, 2246 (2020). PMID: 32382059.
  3. T Florin et al., Pediatrics, [Epub ahead of print] (2020). PMID: 32404432.
  4. A Orlov et al., Biosens Bioelectron, [Epub ahead of print] PMID: 32364940.
  5. M Esbin et al., RNA, [Epub ahead of print] (2020). PMID: 32358057.

About the Author(s)

Luke Turner

While completing my undergraduate degree in Biology, I soon discovered that my passion and strength was for writing about science rather than working in the lab. My master’s degree in Science Communication allowed me to develop my science writing skills and I was lucky enough to come to Texere Publishing straight from University. Here I am given the opportunity to write about cutting edge research and engage with leading scientists, while also being part of a fantastic team!

More Articles by Luke Turner

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.